Literature DB >> 18254119

Psychosocial interventions for smoking cessation in patients with coronary heart disease.

J Barth1, J Critchley, J Bengel.   

Abstract

BACKGROUND: Quitting smoking improves prognosis after a cardiac event, but many patients continue to smoke, and improved cessation aids are urgently required.
OBJECTIVES: To assess the effectiveness of psychosocial interventions such as behavioural therapeutic intervention, telephone support and self-help interventions in helping people with coronary heart disease (CHD) to quit smoking. SEARCH STRATEGY: The Cochrane Central Register of Controlled Trials (issue 2 2003), MEDLINE, EMBASE, PsycINFO and PSYNDEX were searched from the start of the database to August 2003. Results were supplemented by cross-checking references, and handsearches in selected journals and systematic reviews. SELECTION CRITERIA: Randomised controlled studies (RCTs) in patients with CHD with a minimum follow-up of 6 months. After initial selection of the studies three trials with methodological flaws (e.g. high drop out) were excluded. DATA COLLECTION AND ANALYSIS: Abstinence rates were computed according to an intention to treat analysis if possible, or if not on follow-up results only. MAIN
RESULTS: We found 16 RCTs meeting inclusion criteria. Interventions consist of behavioural therapeutic approaches, telephone support and self-help material and were either focused on smoking cessation alone or addressed several risk factors. The trials mostly included older male patients with CHD, predominantly myocardial infarction. Overall there was a positive effect of interventions on abstinence after 6 to 12 months (odds ratio (OR) 1.66, 95% confidence interval (CI) 1.25 to 2.22), but substantial heterogeneity between trials. Studies with validated assessment of smoking status at follow-up had lower efficacy (OR 1.44, 95% CI 0.99 to 2.11) than non-validated trials (OR 1.92, 95% CI 1.26 to 2.93). Studies were clustered by intervention strategy and intensity of the intervention. Clustering reduced heterogeneity, although many trials used more than one type of intervention. The ORs for different strategies were similar (behavioural therapies OR 1.69, 95% CI 1.33 to 2.14; telephone support OR 1.58, 95% CI 1.28 to 1.97; self-help OR 1.48, 95% CI 1.11 to 1.96). More intense interventions showed increased quit rates (OR 1.98, 95% CI 1.49 to 2.65) whereas brief interventions did not appear effective (OR 0.92, 95% CI 0.70 to 1.22). Two trials had longer term follow-up, and did not show any benefits after 5 years. AUTHORS'
CONCLUSIONS: Psychosocial smoking cessation interventions are effective in promoting abstinence at 1 year, provided they are of sufficient duration. Further studies, with longer follow-up, should compare different psychosocial intervention strategies, or the addition of a psychosocial intervention strategy to pharmacological therapy (e.g. nicotine replacement therapy) compared with pharmacological treatment alone.

Entities:  

Mesh:

Year:  2008        PMID: 18254119     DOI: 10.1002/14651858.CD006886

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  17 in total

1.  Understanding and promoting effective self-care during heart failure.

Authors:  Alexander M Clark; Patricia Davidson; Kay Currie; Mehri Karimi; Amanda S Duncan; David R Thompson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-01

2.  Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease.

Authors:  Nadine Berndt; Catherine Bolman; Lilian Lechner; Wendy Max; Aart Mudde; Hein de Vries; Silvia Evers
Journal:  Eur J Health Econ       Date:  2015-03-22

3.  Effectiveness of a telephone delivered and a face-to-face delivered counseling intervention for smoking cessation in patients with coronary heart disease: a 6-month follow-up.

Authors:  Nadine Berndt; Catherine Bolman; Erika Sivarajan Froelicher; Aart Mudde; Math Candel; Hein de Vries; Lilian Lechner
Journal:  J Behav Med       Date:  2013-06-13

4.  Preventing Relapse Following Smoking Cessation.

Authors:  Susan E Collins; Katie Witkiewitz; Megan Kirouac; G Alan Marlatt
Journal:  Curr Cardiovasc Risk Rep       Date:  2010-11

Review 5.  How to promote healthy behaviours in patients? An overview of evidence for behaviour change techniques.

Authors:  Theo van Achterberg; Getty G J Huisman-de Waal; Nicole A B M Ketelaar; Rob A Oostendorp; Johanna E Jacobs; Hub C H Wollersheim
Journal:  Health Promot Int       Date:  2010-08-25       Impact factor: 2.483

6.  Counseling intervention to improve quality of life in patients with pre-existing acute myocardial infarction (AMI) or chronic obstructive pulmonary disease (COPD): a pilot study.

Authors:  G La Torre; R A Cocchiara; E Lo Sordo; M Chiarini; R Siliquini; A Firenze; M Maurici; L Agati; R Saulle; A Mannocci
Journal:  J Prev Med Hyg       Date:  2018-06-01

Review 7.  Psychosocial interventions for supporting women to stop smoking in pregnancy.

Authors:  Catherine Chamberlain; Alison O'Mara-Eves; Sandy Oliver; Jenny R Caird; Susan M Perlen; Sandra J Eades; James Thomas
Journal:  Cochrane Database Syst Rev       Date:  2013-10-23

8.  The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomised controlled trial.

Authors:  Wilhelmina Ijzelenberg; Irene M Hellemans; Maurits W van Tulder; Martijn W Heymans; Jan A Rauwerda; Albert C van Rossum; Jaap C Seidell
Journal:  BMC Cardiovasc Disord       Date:  2012-09-10       Impact factor: 2.298

9.  Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description.

Authors:  Nadine Berndt; Catherine Bolman; Lilian Lechner; Aart Mudde; Freek W A Verheugt; Hein de Vries
Journal:  BMC Cardiovasc Disord       Date:  2012-05-15       Impact factor: 2.298

Review 10.  Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis.

Authors:  Judith J Prochaska; Joan F Hilton
Journal:  BMJ       Date:  2012-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.